These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 11156251

  • 21. Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effects.
    Heise CC, Williams A, Olesch J, Kirn DH.
    Cancer Gene Ther; 1999; 6(6):499-504. PubMed ID: 10608346
    [Abstract] [Full Text] [Related]

  • 22. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC, Wang Y, Hallden G, Brooks G, Francis J, Lemoine NR, Kirn D.
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity.
    Milas M, Yu D, Lang A, Ge T, Feig B, El-Naggar AK, Pollock RE.
    Cancer Gene Ther; 2000 Mar; 7(3):422-9. PubMed ID: 10766348
    [Abstract] [Full Text] [Related]

  • 26. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H, Zhang L, Tang Y, Deisseroth A.
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [Abstract] [Full Text] [Related]

  • 27. Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status.
    Quist SR, Wang-Gohrke S, Köhler T, Kreienberg R, Runnebaum IB.
    Cancer Gene Ther; 2004 Aug; 11(8):547-54. PubMed ID: 15153938
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy.
    Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY, Qian QJ, Liu XY.
    Cell Res; 2003 Dec; 13(6):481-9. PubMed ID: 14728805
    [Abstract] [Full Text] [Related]

  • 30. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
    Zhang Z, Zou W, Wang J, Gu J, Dang Y, Li B, Zhao L, Qian C, Qian Q, Liu X.
    Mol Ther; 2005 Apr; 11(4):553-62. PubMed ID: 15771958
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.
    Rogulski KR, Freytag SO, Zhang K, Gilbert JD, Paielli DL, Kim JH, Heise CC, Kirn DH.
    Cancer Res; 2000 Mar 01; 60(5):1193-6. PubMed ID: 10728673
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.
    Reles A, Wen WH, Schmider A, Gee C, Runnebaum IB, Kilian U, Jones LA, El-Naggar A, Minguillon C, Schönborn I, Reich O, Kreienberg R, Lichtenegger W, Press MF.
    Clin Cancer Res; 2001 Oct 01; 7(10):2984-97. PubMed ID: 11595686
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.
    Mulvihill S, Warren R, Venook A, Adler A, Randlev B, Heise C, Kirn D.
    Gene Ther; 2001 Feb 01; 8(4):308-15. PubMed ID: 11313805
    [Abstract] [Full Text] [Related]

  • 39. The role of p53 in the chemotherapeutic responses to cisplatin, doxorubicin and 5-fluorouracil treatment.
    Dart DA, Picksley SM, Cooper PA, Double JA, Bibby MC.
    Int J Oncol; 2004 Jan 01; 24(1):115-25. PubMed ID: 14654948
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.